<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Li J</submitter><funding>National Institute of Allergy and Infectious Diseases</funding><funding>NIDCR NIH HHS</funding><funding>NIAID NIH HHS</funding><funding>National Cancer Institute</funding><funding>National Institute of Dental and Craniofacial Research</funding><funding>NCI NIH HHS</funding><pagination>eaaw7373</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6785261</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>5(10)</volume><pubmed_abstract>Protein nuclear translocation is highly regulated and crucial for diverse biological processes. However, our understanding concerning protein nuclear import is incomplete. Here we report that a cellular purine synthesis enzyme inhibits protein nuclear import via deamidation. Employing human Kaposi's sarcoma-associated herpesvirus (KSHV) to probe the role of protein deamidation, we identified a purine synthesis enzyme, phosphoribosylformylglycinamidine synthetase (PFAS) that inhibits KSHV transcriptional activation. PFAS deamidates the replication transactivator (RTA), a transcription factor crucial for KSHV lytic replication. Mechanistically, deamidation of two asparagines flanking a positively charged nuclear localization signal impaired the binding of RTA to an importin β subunit, thus d</pubmed_abstract><journal>Science advances</journal><pubmed_title>Antiviral activity of a purine synthesis enzyme reveals a key role of deamidation in regulating protein nuclear import.</pubmed_title><pmcid>PMC6785261</pmcid><funding_grant_id>DE026003</funding_grant_id><funding_grant_id>DE027556</funding_grant_id><funding_grant_id>P01 CA180779</funding_grant_id><funding_grant_id>R03 DE022521</funding_grant_id><funding_grant_id>R35 DE027557</funding_grant_id><funding_grant_id>R01 CA203923</funding_grant_id><funding_grant_id>R35 DE027556</funding_grant_id><funding_grant_id>AI134105</funding_grant_id><funding_grant_id>CA221521</funding_grant_id><funding_grant_id>R01 CA221521</funding_grant_id><funding_grant_id>R21 AI134105</funding_grant_id><pubmed_authors>Tarakanova V</pubmed_authors><pubmed_authors>Li J</pubmed_authors><pubmed_authors>Tian M</pubmed_authors><pubmed_authors>Zhang J</pubmed_authors><pubmed_authors>Lee K</pubmed_authors><pubmed_authors>Zeng Y</pubmed_authors><pubmed_authors>Zhang S</pubmed_authors><pubmed_authors>Gao R</pubmed_authors><pubmed_authors>Xiao J</pubmed_authors><pubmed_authors>Feng H</pubmed_authors><pubmed_authors>Lan K</pubmed_authors><pubmed_authors>Xu S</pubmed_authors><pubmed_authors>Zhao J</pubmed_authors><pubmed_authors>Feng P</pubmed_authors></additional><is_claimable>false</is_claimable><name>Antiviral activity of a purine synthesis enzyme reveals a key role of deamidation in regulating protein nuclear import.</name><description>Protein nuclear translocation is highly regulated and crucial for diverse biological processes. However, our understanding concerning protein nuclear import is incomplete. Here we report that a cellular purine synthesis enzyme inhibits protein nuclear import via deamidation. Employing human Kaposi's sarcoma-associated herpesvirus (KSHV) to probe the role of protein deamidation, we identified a purine synthesis enzyme, phosphoribosylformylglycinamidine synthetase (PFAS) that inhibits KSHV transcriptional activation. PFAS deamidates the replication transactivator (RTA), a transcription factor crucial for KSHV lytic replication. Mechanistically, deamidation of two asparagines flanking a positively charged nuclear localization signal impaired the binding of RTA to an importin β subunit, thus d</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Oct</publication><modification>2025-04-19T17:10:25.709Z</modification><creation>2019-10-30T08:19:13Z</creation></dates><accession>S-EPMC6785261</accession><cross_references><pubmed>31633017</pubmed><doi>10.1126/sciadv.aaw7373</doi></cross_references></HashMap>